Compare · CHB vs JHB
CHB vs JHB
Side-by-side comparison of Global X China Biotech Innovation ETF (CHB) and Nuveen High Income November 2021 Target Term Fund (JHB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHB and JHB operate in n/a (n/a), so they compete in similar markets.
- JHB carries a market cap of $525.4M.
Global X China Biotech Innovation ETF
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index ("underlying index"). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in Chinaâs biotechnology industry. It is non-diversified.
Latest CHB
Latest JHB
- SEC Form NPORT-P filed by Nuveen High Income November 2021 Target Term Fund
- Nuveen Corporate Income November 2021 Target Term Fund Announces Termination and Liquidation
- SEC Form 25-NSE filed by Nuveen High Income November 2021 Target Term Fund
- Nuveen Corporate Income November 2021 Target Term Fund Announces Liquidation Details
- SEC Form N-CSRS filed by Nuveen High Income November 2021 Target Term Fund
- SEC Form NPORT-P filed by Nuveen High Income November 2021 Target Term Fund
- SEC Form N-PX filed by Nuveen High Income November 2021 Target Term Fund
- SEC Form 3 filed by Lancellotta Amy B.R.
- Nuveen Corporate Income November 2021 Target Term Fund Announces Wind-Up Period
- SEC Form NPORT-P filed by Nuveen High Income November 2021 Target Term Fund